Risankizumab (anti-IL-23)
Product Specifications
CAS Number
1612838-76-2
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Risankizumab targets the p19 subunit of IL-23. Risankizumab is indicated for the treatment of psoriasis and is safe and effective in maintaining remission in active Crohn's disease.
Storage Conditions
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBP1-43415-0.1mg 0.1 mg
Rat Monoclonal Integrin alpha 2b/CD41 Antibody (MWReg30)
Sign In for Pricing
View Details 
